These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3390793)

  • 1. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases.
    Fallenius AG; Franzén SA; Auer GU
    Cancer; 1988 Aug; 62(3):521-30. PubMed ID: 3390793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
    Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
    Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
    Erhardt K; Silfverswärd C; Auer G
    Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
    Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignancy grading in breast cancer as assessed by nuclear DNA content].
    Nishi T; Okajima K; Taguchi T; Mizutani H; Sogabe T; Uragami I; Sekimoto T
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):576-81. PubMed ID: 3405196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
    Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
    Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.
    von Rosen A; Rutqvist LE; Carstensen J; Fallenius A; Skoog L; Auer G
    Breast Cancer Res Treat; 1989 Jan; 13(1):23-32. PubMed ID: 2706326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear DNA content of fine needle aspirates of invasive ductal carcinomas of the breast.
    Sarker S; Spigelman A; Walker M; Coleman D
    Anal Cell Pathol; 1997; 13(1):1-8. PubMed ID: 9154308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients.
    Fallenius AG; Auer GU; Carstensen JM
    Cancer; 1988 Jul; 62(2):331-41. PubMed ID: 3383134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of nuclear DNA content in breast cancer].
    Nishi T; Okajima K; Taguchi T; Ryo T; Mizutani H; Kawashima Y; Sekimoto T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):569-77. PubMed ID: 2351850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content, tumor cell aggregation, and metastatic events in patients with poorly differentiated adenocarcinoma of the stomach.
    Watanabe A; Korenaga D; Maehara Y; Sugimachi K
    Cancer; 1991 Aug; 68(4):815-20. PubMed ID: 1855182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
    Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
    Hedley DW; Rugg CA; Ng AB; Taylor IW
    Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
    Azavedo E; Fallenius A; Svane G; Auer G
    Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.
    Isobe H; Miyamoto H; Shimizu T; Haneda H; Hashimoto M; Inoue K; Mizuno S; Kawakami Y
    Cancer; 1990 Mar; 65(6):1391-5. PubMed ID: 2155055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.